We are live on
!
Find out more
DDC
Daniel Devine & Co Portfolio holdings
AUM
$125M
1-Year Est. Return
14.12%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$753K
(+0.62%)
Cap. Flow
-$3.3M
Cap. Flow
% of AUM
-2.69%
Top 10 Holdings %
Top 10 Hldgs %
70.45%
Holding
48
New
1
Increased
1
Reduced
30
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Valvoline
VVV
|
+$769K |
| 2 |
HBI
Hanesbrands
HBI
|
+$6.47K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ashland
ASH
|
+$842K |
| 2 |
GE Aerospace
GE
|
+$306K |
| 3 |
Pfizer
PFE
|
+$280K |
| 4 |
AbbVie
ABBV
|
+$255K |
| 5 |
Blackstone
BX
|
+$251K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Financials | 6.92% |
| 3 | Technology | 6.6% |
| 4 | Industrials | 4.29% |
| 5 | Energy | 3.23% |
Similar funds
PMLI
KFA
FAM
MFP
MGA
MAI
XGI
ACM
Daniel Devine & Co's Q2 2017 Portfolio in Review
As of Q2 2017, Daniel Devine & Co held 48 positions worth $123M, up 0.62% from $122M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 4.2%. Daniel Devine & Co opened 1 new position and exited 1, leaving the 48-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Financials and Technology.
- Daniel Devine & Co's largest Q2 2017 buy was Valvoline: 33,186 shares worth $787K.
- Daniel Devine & Co added most to Hanesbrands in Q2 2017, an estimated $6.47K increase.
- Daniel Devine & Co's biggest Q2 2017 reduction was Ashland, cutting an estimated $842K.
- Daniel Devine & Co's ten largest holdings make up 70% of its $123M portfolio in Q2 2017.
- Daniel Devine & Co opened 1 new position and closed 1 in Q2 2017.
- Daniel Devine & Co's portfolio value rose 0.62% quarter-over-quarter to $123M.
Based on Daniel Devine & Co's 13F filing for Q2 2017, filed 20 Jul 2017.